Inhibitors of the N-Terminal Domain of the Androgen Receptor
Copyright © Targeted News Service 2024
2024-12-10
ALEXANDRIA, Virginia, Dec. 10 -- THE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, Washington, District of Columbia has been assigned a patent (No. US 12162818 B2, initially filed Jan. 13, 2022) developed by four inventors Matthew Rettig, Los Angeles, California; Michael E. Jung, Los Angeles, California; D. Elshan Nakath G. Ralalage, Los Angeles, California; and Jiabin An, Los Angeles, California, for "Inhibitors of the n-terminal domain of the androgen receptor." . . .